Zivo Bioscience, Inc.
ZIVO
$6.96
-$2.54-26.74%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 22.85% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.85% | -- | |||
| Cost of Revenue | 24.79% | -- | |||
| Gross Profit | 18.99% | -- | |||
| SG&A Expenses | -28.60% | -18.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.72% | -59.93% | |||
| Operating Income | 37.64% | 61.20% | |||
| Income Before Tax | 37.01% | 61.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 37.01% | 61.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.01% | 61.05% | |||
| EBIT | 37.64% | 61.20% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 37.14% | 61.67% | |||
| Normalized Basic EPS | 37.16% | 61.66% | |||
| EPS Diluted | 37.14% | 61.67% | |||
| Normalized Diluted EPS | 37.16% | 61.66% | |||
| Average Basic Shares Outstanding | 0.19% | 1.60% | |||
| Average Diluted Shares Outstanding | 0.19% | 1.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||